The stock of Inspire Medical Systems Inc (INSP) has gone down by -5.34% for the week, with a -19.50% drop in the past month and a -19.03% drop in the past quarter. The volatility ratio for the week is 1.93%, and the volatility levels for the past 30 days are 1.86% for INSP. The simple moving average for the last 20 days is -8.59% for INSP stock, with a simple moving average of -28.29% for the last 200 days.
Is It Worth Investing in Inspire Medical Systems Inc (NYSE: INSP) Right Now?
Inspire Medical Systems Inc (NYSE: INSP) has a price-to-earnings ratio of 59.27x that is above its average ratio. Additionally, the 36-month beta value for INSP is 1.28. There are mixed opinions on the stock, with 8 analysts rating it as a “buy,” 5 rating it as “overweight,” 5 rating it as “hold,” and 0 rating it as “sell.”
The public float for INSP is 27.62M and currently, short sellers hold a 11.60% ratio of that float. The average trading volume of INSP on June 13, 2025 was 487.65K shares.
INSP) stock’s latest price update
The stock of Inspire Medical Systems Inc (NYSE: INSP) has decreased by -3.10 when compared to last closing price of 132.72. Despite this, the company has experienced a -5.34% fall in its stock price over the last five trading sessions. zacks.com reported 2025-06-12 that Investors need to pay close attention to INSP stock based on the movements in the options market lately.
Analysts’ Opinion of INSP
Many brokerage firms have already submitted their reports for INSP stocks, with BofA Securities repeating the rating for INSP by listing it as a “Buy.” The predicted price for INSP in the upcoming period, according to BofA Securities is $255 based on the research report published on November 20, 2024 of the previous year 2024.
BofA Securities, on the other hand, stated in their research note that they expect to see INSP reach a price target of $225, previously predicting the price at $265. The rating they have provided for INSP stocks is “Neutral” according to the report published on May 08th, 2024.
RBC Capital Mkts gave a rating of “Outperform” to INSP, setting the target price at $285 in the report published on April 19th of the previous year.
INSP Trading at -13.12% from the 50-Day Moving Average
After a stumble in the market that brought INSP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -42.84% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at INSP starting from Rondoni John, who sale 1,734 shares at the price of $149.38 back on May 19 ’25. After this action, Rondoni John now owns 13,766 shares of Inspire Medical Systems Inc, valued at $259,025 using the latest closing price.
JOHN RONDONI, the Officer of Inspire Medical Systems Inc, proposed sale 1,734 shares at $149.38 during a trade that took place back on May 19 ’25, which means that JOHN RONDONI is holding shares at $259,025 based on the most recent closing price.
Stock Fundamentals for INSP
Current profitability levels for the company are sitting at:
- 0.06 for the present operating margin
- 0.85 for the gross margin
The net margin for Inspire Medical Systems Inc stands at 0.08. The total capital return value is set at 0.07. Equity return is now at value 10.86, with 9.39 for asset returns.
Based on Inspire Medical Systems Inc (INSP), the company’s capital structure generated 0.05 points at debt to capital in total, while cash flow to debt ratio is standing at 3.64. The debt to equity ratio resting at 0.05. The interest coverage ratio of the stock is 2264.36.
Currently, EBITDA for the company is 65.03 million with net debt to EBITDA at -0.29. When we switch over and look at the enterprise to sales, we see a ratio of 4.49. The receivables turnover for the company is 9.07for trailing twelve months and the total asset turnover is 1.15. The liquidity ratio also appears to be rather interesting for investors as it stands at 9.01.
Conclusion
In conclusion, Inspire Medical Systems Inc (INSP) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
